Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
Medtronic
AstraZeneca
Johnson and Johnson
US Department of Justice
Citi
Deloitte
Federal Trade Commission

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020068

« Back to Dashboard

NDA 020068 describes FOSCAVIR, which is a drug marketed by Clinigen Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the FOSCAVIR profile page.

The generic ingredient in FOSCAVIR is foscarnet sodium. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the foscarnet sodium profile page.
Summary for 020068
Tradename:FOSCAVIR
Applicant:Clinigen Hlthcare
Ingredient:foscarnet sodium
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Pharmacology for NDA: 020068
Medical Subject Heading (MeSH) Categories for 020068
Suppliers and Packaging for NDA: 020068
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068 NDA Clinigen Healthcare Ltd. 76310-024 N 76310-024-25
FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068 NDA Clinigen Healthcare Ltd. 76310-024 N 76310-024-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2.4GM/100ML
Approval Date:Sep 27, 1991TE:RLD:Yes

Expired US Patents for NDA 020068

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Healthtrust
Cerilliant
Citi
Daiichi Sankyo
Federal Trade Commission
Express Scripts
McKesson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.